GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neutra Corp (OTCPK:NTRR) » Definitions » ROCE %

Neutra (Neutra) ROCE % : 0.00% (As of Oct. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Neutra ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Neutra's annualized ROCE % for the quarter that ended in Oct. 2023 was 0.00%.


Neutra ROCE % Historical Data

The historical data trend for Neutra's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neutra ROCE % Chart

Neutra Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Neutra Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Neutra ROCE % Calculation

Neutra's annualized ROCE % for the fiscal year that ended in Jan. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Jan. 2023 )  (A: Jan. 2022 )(A: Jan. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Jan. 2023 )  (A: Jan. 2022 )(A: Jan. 2023 )
=-0.496/( ( (0.131 - 1.154) + (0.075 - 0.76) )/ 2 )
=-0.496/( (-1.023+-0.685)/ 2 )
=-0.496/-0.854
=58.08 %

Neutra's ROCE % of for the quarter that ended in Oct. 2023 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Oct. 2023 )  (Q: Jul. 2023 )(Q: Oct. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Oct. 2023 )  (Q: Jul. 2023 )(Q: Oct. 2023 )
=-0.212/( ( (0.037 - 0.864) + (0.027 - 0.909) )/ 2 )
=-0.212/( ( -0.827 + -0.882 )/ 2 )
=-0.212/-0.8545
=0 %

(1) Note: The EBIT data used here is four times the quarterly (Oct. 2023) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Neutra  (OTCPK:NTRR) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Neutra ROCE % Related Terms

Thank you for viewing the detailed overview of Neutra's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Neutra (Neutra) Business Description

Traded in Other Exchanges
N/A
Address
54 Sugar Creek Center Boulevard, Suite 200, Sugar Land, TX, USA, 77478
Neutra Corp is a development-stage company, which intends to market and participate in the nutraceutical space by bringing products derived from all natural and organic origins. Along with participating in the actual nutraceutical products, the company plans to research and bring new technology to the Nutraceutical space. Nutraceutical natural medicine is an alternative system that focuses on natural remedies and the body's vital ability to heal and maintain itself. It focuses on the areas of anti-aging, sleep disorders, pain management, and others. Geographically, all the activities are operated through the region of the United States.
Executives
Sydney Jim director, officer: CEO & Chairman 8875 HIDDEN RIVER PARKWAY, SUITE 300, TAMPA FL 34243